Company Quick10K Filing
Insulet
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$151.45 60 $9,038
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-05 Earnings, Exhibits
8-K 2019-09-16 Other Events
8-K 2019-09-06 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-09-04 Regulation FD, Exhibits
8-K 2019-09-03 Regulation FD, Exhibits
8-K 2019-08-05 Earnings, Exhibits
8-K 2019-07-31 Exhibits
8-K 2019-05-30 Exhibits
8-K 2019-05-02 Earnings, Exhibits
8-K 2019-04-29 Officers
8-K 2019-02-25 Earnings, Exhibits
8-K 2019-01-25 Regulation FD, Exhibits
8-K 2019-01-25 Regulation FD, Exhibits
8-K 2019-01-03 Earnings, Exhibits
8-K 2018-11-01 Earnings, Exhibits
8-K 2018-10-16 Officers, Exhibits
8-K 2018-09-10 Regulation FD, Exhibits
8-K 2018-08-02 Earnings, Exhibits
8-K 2018-06-29 Enter Agreement
8-K 2018-05-16 Shareholder Vote
8-K 2018-05-07 Enter Agreement, Leave Agreement, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-05-03 Earnings, Exhibits
8-K 2018-04-27 Exhibits
8-K 2018-02-21 Earnings, Exhibits

Insulet Financials

-

PODD Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Dexcom (DXCM) 12,908 2,066 1,378 1,222 767 -170 -87 12,198
Dentsply Sirona (XRAY) 13,003 8,575 3,392 0 2,041 105 478 14,194
Insulet (PODD) 7,136 978 728 661 435 17 47 7,624
Novocure (NVCR) 5,679 406 247 294 212 -41 -16 5,646
Abiomed (ABMD) 11,806 1,125 122 797 661 258 327 11,705
Hill-Rom Holdings (HRC) 7,067 4,575 2,951 2,884 1,415 215 335 8,663
Haemonetics (HAE) 6,085 1,260 669 727 450 49 176 6,331
Globus Medical (GMED) 4,300 1,391 103 743 573 143 221 4,182
Integra Lifesciences (IART) 4,669 3,290 1,869 1,493 930 101 262 5,393
Penumbra (PEN) 6,047 585 131 495 332 15 23 5,969
Tandem Diabetes Care (TNDM) 3,601 255 110 282 147 -55 -49 3,470
Cantel Medical (CMD) 3,630 1,070 409 0 427 55 126 3,816
ICU Medical (ICUI) 5,345 1,623 305 1,311 508 47 127 5,031
Nuvasive (NUVA) 3,283 1,805 1,127 814 52 194 3,765
Nevro (NVRO) 1,957 448 246 379 261 -93 -77 2,049
Glaukos (GKOS) 2,779 302 114 211 182 -12 -7 2,730
Merit Medical Systems (MMSI) 3,357 1,736 786 949 423 39 141 3,722
iRhythm Technologies (IRTC) 1,941 207 159 182 137 -44 -40 1,923
Cardiovascular Systems (CSII) 1,490 219 71 248 200 -0 4 1,416
Inspire Medical Systems (INSP) 1,451 186 33 64 52 -25 -23 1,424

Balance Sheet ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash9483706357148151154150146176146151146145145123112762151377673102273203136127114129120
Accounts Receivable23262630333134343337424740363232484039392941384753505070636967
Inventory121516151596591091013202313141424333634343534264158717485
PP&E422021255325293167333437604542427042415188657688159153198229324300334
Assets210204192192198281286289288289325301302306300293275255263453457445459500817830839886929953978
Accounts Payable11161416991115192119181514181619132218136122924342527262725
Long-Term Debt
Liabilities138145144153154151148168163166242221218225230238241228236388393381395426658659660688717729728
Stockholders' Equity71594839441301381211251227880848170553426276563646574159171179198212224250
Income Statement ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue47485255585760616969807573617687100818795104102110122131124124151165160186
Cost of Revenue27272930333233343636363736284152553737394342454851484249555361
Gross Profit202023242525272733334138373334364544505661596574807682102110107116
R&D5774566777781210131313141618182019201822293232
SG&A2626262727392628343432333541563939394947505161565973666777
Tax000000-0000000000000000-0000100
Net Income-14-15-14-12-10-11-11-21-2-6-14-11-5-12-15-19-27-12-4-3-9-10-8-2-7-7-221041
Cash Flow ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-9-11-3-144-4-1155-319-19-114320-22182322-4-61630614
Cash Investing-2-3-5-1-2-2-3-2-4-3-3-4-0-7-31-37-45-97-42-223-149-56-61-27-418-39
Cash Financing-01193012-133-3132-1-1-1-2-2182-1312298-911-2216